Verastem (VSTM) Long-Term Debt Repayments (2025)
Verastem (VSTM) posted Long-Term Debt Repayments of -$1,000 for Q4 2025.
Powered by 
Analysis
Verastem (VSTM) Long-Term Debt Repayments (2025) Analysis & Trends
For FY2025, Verastem's Long-Term Debt Repayments came in at $42.58 million.
- Annual Long-Term Debt Repayments shows a five-year compound annual growth rate of 2.6% (FY2020 to FY2025).
- In prior years, Verastem's Long-Term Debt Repayments was $300,000 in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,148.13 Bn | 1,116.72 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 630.09 Bn | 548.62 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 498.99 Bn | 472.10 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 374.92 Bn | 329.30 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 300.99 Bn | 264.98 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 264.63 Bn | 238.32 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 239.15 Bn | 194.55 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 192.23 Bn | 166.43 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | Verastem | 919.21 Mn | 275.83 Mn | 36.32 Mn | - |
API Access
Verastem Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=VSTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "VSTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=VSTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();